RBD1016
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RBD1016, covering 2024-12-06 to 2026-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis D [Phase 2]